

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital d⦠read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
$56.21
Price-1.13%
-$0.64
$3.500b
Mid
-
Premium
Premium
-23.2%
EBITDA Margin-29.4%
Net Profit Margin-33.5%
Free Cash Flow Margin-23.2%
EBITDA Margin-29.4%
Net Profit Margin-33.5%
Free Cash Flow Margin$409.479m
+4.0%
1y CAGR+17.3%
3y CAGR+18.1%
5y CAGR-$81.276m
+1.4%
1y CAGR+20.7%
3y CAGR+17.1%
5y CAGR-$1.33
+1.5%
1y CAGR+21.8%
3y CAGR+19.1%
5y CAGR$455.094m
$676.214m
Assets$221.120m
Liabilities$95.841m
Debt14.2%
-3.6x
Debt to EBITDA-$95.140m
-14.7%
1y CAGR+11.8%
3y CAGR+15.0%
5y CAGR